Use of antimicrobial agents in United States neonatal and pediatric intensive care patients.

@article{Grohskopf2005UseOA,
  title={Use of antimicrobial agents in United States neonatal and pediatric intensive care patients.},
  author={Lisa A. Grohskopf and W. Charles Huskins and Ronda L Sinkowitz-Cochran and Gail L. Levine and Donald A. Goldmann and William Robert Jarvis},
  journal={The Pediatric infectious disease journal},
  year={2005},
  volume={24 9},
  pages={766-73}
}
OBJECTIVE Antimicrobial use contributes to the development of emergence and dissemination of antimicrobial-resistant bacteria among intensive care unit (ICU) patients. There are few published data on antimicrobial use in neonatal (NICU) and pediatric ICU (PICU) patients. METHODS Personnel at 31 Pediatric Prevention Network hospitals participated in point prevalence surveys on August 4, 1999 (summer) and February 8, 2000 (winter). Data collected for all NICU and PICU inpatients included… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
The most common agents among NICU patients were gentamicin , ampicillin and vancomycin ; the most common agents among PICU patients were cefazolin , vancomycin and cefotaxime .
The most common agents among NICU patients were gentamicin , ampicillin and vancomycin ; the most common agents among PICU patients were cefazolin , vancomycin and cefotaxime .
There are few published data on antimicrobial use in neonatal ( NICU ) and pediatric ICU ( PICU ) patients .
There are few published data on antimicrobial use in neonatal ( NICU ) and pediatric ICU ( PICU ) patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
Use of aminoglycosides , aminopenicillins and topical antibacterials was significantly more common in NICU patients ; first , second and third generation cephalosporins , extended spectrum penicillins , sulfonamides , fluoroquinolones , antianaerobic agents , systemic antifungals and systemic antivirals were more common in PICU patients .
All Topics